Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|34|5294-5299

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.34, 2016-09, pp. : 5294-5299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutations of factor H (HF) in familial Hemolytic Uremic Syndrome (HUS) / Thrombotic Thrombocytopenic Purpura (TTP)

By Caprioli J.   Bettinaglio P.   Zipfel P.F.   Vasile B.   Gamba S.   Amadei B.   Orisio S.   Remuzzi G.   Noris M.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 13-13

Elsevier

Access to resources Recommend Favorite

The Uremic Toxin Indoxyl-3-Sulfate Induces CYP1A2 In Primary Human Hepatocytes

By  

Drug Metabolism Letters, Vol. 10, Iss. 3, 2016-09 ,pp. : 195-199

Bentham Science Publishers

Access to resources Recommend Favorite

Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 814-822

Bentham Science Publishers

Access to resources Recommend Favorite

Marine natural products as therapeutic agents: Part 2

By Frenz Jamie L   Kohl Amber C   Kerr Russell G  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 17-33

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite